Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia
Status:
Unknown status
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
With calcium carbonate as the positive control drug, to observe the effectiveness and safety
of nicotinic acid in hemodialysis patients with hyperphosphatemia